With reference to the earlier announcement dated September 05, 2003, December 01, 2003, April 13, 2007, May 05, 2007 regarding notices received by the Company from the National Pharmaceutical Pricing Authority, Government of India demanding an aggregate of Rs 941.92 crores alongwith interest which according to them was allegedly overcharged by the Company till March 2006 in respect of five drugs, Cipla Ltd has informed that the Company has now received further demand notice where the Government has demanded an amount of Rs 49.47 crores inclusive of interest which according to them was allegedly overcharged by the Company during the period April 2006 to March 2007 in respect of the drug Salbutamol. These notices are contrary to the orders of the Hon'ble Supreme Court of India and the Company has received legal advice that entire amounts demanded by the Government are not tenable and sustainable.
No comments:
Post a Comment